MedPath

Efficacy and Safety of Chelation Therapy with Calcium Disodium EDTA (ethylenediaminetetraacetic acid) in the Progression of Chronic Kidney Disease of Unknown Etiology in Sri Lanka

Phase 3
Not yet recruiting
Conditions
Chronic Kidney Disease of Unknown Etiology
Registration Number
SLCTR/2018/021
Lead Sponsor
niversity of Colombo
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

1. Males and females aged between 18 and 75 years
2. Stages 1-3 of chronic kidney disease of unknown origin
3. High cadmium body burden (urinary cadmium levels > 4.94ug per g of creatinine according to WHO/ FAO toxicokinetic model).

Exclusion Criteria

1. Patients with acute myocardial infarction or stroke in the previous six months
2. Hypertension
3. Diabetes
4. Patients with cancers
5. Known cardiac arrhythmias
6. Seizures disorders
7. Known hypersensitivity to Calcium Disodium EDTA
8. Hypocalcaemia
9. Pregnancy and breast feeding

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.